title: Prenylation of Rho G-proteins: a novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells.
abstract: Endogenous prenylation with sesquiterpene or diterpene isoprenoids facilitates membrane localization and functional activation of small monomeric GTP-binding proteins. A direct effect of isoprenoids on regulation of gene expression and protein stability has also been proposed. In this study, we determined the role of sesquiterpene or diterpene isoprenoids on the regulation of Rho G-protein expression, activation, and stability in human trabecular meshwork (TM) cells. In both primary and transformed human TM cells, limiting endogenous isoprenoid synthesis with lovastatin, a potent HMG-CoA reductase inhibitor, elicited marked increases in RhoA and RhoB mRNA and protein content. The effect of lovastatin was dose-dependent with newly synthesized inactive protein accumulating in the cytosol. Supplementation with geranylgeranyl pyrophosphate (GGPP) prevented, while inhibition of geranylgeranyl transferase-I mimicked, the effects of lovastatin on RhoA and RhoB protein content. Similarly, lovastatin-dependent increases in RhoA and RhoB mRNA expression were mimicked by geranylgeranyl transferase-I inhibition. Interestingly, GGPP supplementation selectively promoted the degradation of newly synthesized Rho proteins which was mediated, in part, through the 20S proteasome. Functionally, GGPP supplementation prevented lovastatin-dependent decreases in actin stress fiber organization while selectively facilitating the subcellular redistribution of accumulated Rho proteins from the cytosol to the membrane and increasing RhoA activation. Post-translational prenylation with geranylgeranyl diterpenes selectively facilitates the expression, membrane translocation, functional activation, and turnover of newly synthesized Rho proteins. Geranylgeranyl prenylation represents a novel mechanism by which active Rho proteins are targeted to the 20S proteasome for degradation in human TM cells.
authors.affiliation: Research Service, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, IL 60141, USA. evan.stubbs@va.gov
authors.forename: Evan B
authors.initials: EB
authors.lastname: Stubbs
authors.forename: Cynthia L
authors.initials: CL
authors.lastname: Von Zee
mesh_terms: D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors / Q000378:metabolism; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008148:Lovastatin / Q000494:pharmacology; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D011106:Polyisoprenyl Phosphates / Q000494:pharmacology; D054876:Prenylation / Q000187:drug effects; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D055550:Protein Stability / Q000187:drug effects; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D059748:Proteolysis / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D022502:Stress Fibers / Q000187:drug effects / Q000378:metabolism; D014129:Trabecular Meshwork / Q000187:drug effects / Q000378:metabolism*; D020741:rho GTP-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D020743:rhoB GTP-Binding Protein / Q000378:metabolism
chemical_list: D009842:Oligopeptides; D011106:Polyisoprenyl Phosphates; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D008148:Lovastatin; D019883:Alkyl and Aryl Transferases; C083291:geranylgeranyltransferase type-I; D046988:Proteasome Endopeptidase Complex; D020741:rho GTP-Binding Proteins; D020743:rhoB GTP-Binding Protein; C002963:geranylgeranyl pyrophosphate; C078846:epoxomicin